Key Insights

Highlights

Treatment Research

1 treatments under study, led by Docetaxel

Research Leaders

8 sponsors active, led by Nader Sadeghi

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT04277858Phase 2Unknown

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

NCT05904327Active Not Recruiting

Circulating Biomarkers in Oropharyngeal Cancers

Showing all 2 trials

Research Network

Common Treatments

  • Docetaxel1

Active Sponsors

  • Nader Sadeghi1
  • McGill University Health Centre/Research Institute of the McGill University Health Centre1
  • Region Stockholm1
  • Region Västmanland1
  • Dalarna County Council, Sweden1

Top Investigators

Related Conditions

  • Oropharynx Cancer2
  • Throat Cancer1
  • Tonsillar Cancer1
  • Oropharynx Squamous Cell Carcinoma1
  • Tonsil Cancer1

Activity Timeline